1. Home
  2. EVOK vs CYCN Comparison

EVOK vs CYCN Comparison

Compare EVOK & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • CYCN
  • Stock Information
  • Founded
  • EVOK 2007
  • CYCN 2018
  • Country
  • EVOK United States
  • CYCN United States
  • Employees
  • EVOK N/A
  • CYCN N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVOK Health Care
  • CYCN Health Care
  • Exchange
  • EVOK Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • EVOK 7.1M
  • CYCN 8.4M
  • IPO Year
  • EVOK 2013
  • CYCN N/A
  • Fundamental
  • Price
  • EVOK $4.81
  • CYCN $4.21
  • Analyst Decision
  • EVOK
  • CYCN
  • Analyst Count
  • EVOK 0
  • CYCN 0
  • Target Price
  • EVOK N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • EVOK 10.0K
  • CYCN 5.8M
  • Earning Date
  • EVOK 03-13-2025
  • CYCN 03-04-2025
  • Dividend Yield
  • EVOK N/A
  • CYCN N/A
  • EPS Growth
  • EVOK N/A
  • CYCN N/A
  • EPS
  • EVOK N/A
  • CYCN N/A
  • Revenue
  • EVOK $8,617,036.00
  • CYCN $194,000.00
  • Revenue This Year
  • EVOK $97.35
  • CYCN N/A
  • Revenue Next Year
  • EVOK $99.52
  • CYCN N/A
  • P/E Ratio
  • EVOK N/A
  • CYCN N/A
  • Revenue Growth
  • EVOK 100.35
  • CYCN N/A
  • 52 Week Low
  • EVOK $3.54
  • CYCN $1.27
  • 52 Week High
  • EVOK $12.32
  • CYCN $9.47
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 59.77
  • CYCN 58.42
  • Support Level
  • EVOK $4.68
  • CYCN $2.81
  • Resistance Level
  • EVOK $4.94
  • CYCN $6.25
  • Average True Range (ATR)
  • EVOK 0.28
  • CYCN 0.67
  • MACD
  • EVOK 0.06
  • CYCN 0.17
  • Stochastic Oscillator
  • EVOK 73.58
  • CYCN 48.35

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: